Literature DB >> 18003639

Pink1 Parkinson mutations, the Cdc37/Hsp90 chaperones and Parkin all influence the maturation or subcellular distribution of Pink1.

Andreas Weihofen1, Beth Ostaszewski, Yasufumi Minami, Dennis J Selkoe.   

Abstract

Mutations in the ubiquitously expressed gene PTEN-induced kinase 1 (Pink1) cause autosomal recessive Parkinson's disease. Pink1 encodes a putative serine/threonine kinase with an N-terminal mitochondrial targeting sequence. The mechanism that leads to selective degeneration of dopaminergic neurons via Pink1 mutations is unknown. A full-length pre-protein (66 kDa) and an N-terminally truncated mature form (55 kDa) have been described in human brain. Here, we report that the endogenous 66 kDa and 55 kDa Pink1 forms in cultured cells are not exclusive to mitochondria but also occur in cytosolic and microsome-rich fractions. Pink1 66 kDa is the predominant isoform in cultured cells. Using unbiased analyses of immunoisolated Pink1 complexes by mass spectrometry, co-immunoprecipitation and Hsp90 inhibitor studies, we identify Pink1 as a novel Cdc37/Hsp90 client kinase. This chaperone system influences both the subcellular distribution and the 66/55 kDa protein ratio of Pink1. PD-causing Pink1 mutations decrease whereas Parkin expression increases the Pink1 66/55 kDa protein ratio, biochemically linking Pink1 and Parkin and highlighting the potential relevance of this ratio for PD pathogenesis. Finally, we document the influence of Parkin on Pink1 subcellular distribution, providing further evidence for a common pathogenic pathway in recessive PD.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 18003639     DOI: 10.1093/hmg/ddm334

Source DB:  PubMed          Journal:  Hum Mol Genet        ISSN: 0964-6906            Impact factor:   6.150


  71 in total

1.  Pink1 kinase and its membrane potential (Deltaψ)-dependent cleavage product both localize to outer mitochondrial membrane by unique targeting mode.

Authors:  Dorothea Becker; Judith Richter; Maja A Tocilescu; Serge Przedborski; Wolfgang Voos
Journal:  J Biol Chem       Date:  2012-04-30       Impact factor: 5.157

Review 2.  Function of cytosolic chaperones in Tom70-mediated mitochondrial import.

Authors:  Anna C Y Fan; Jason C Young
Journal:  Protein Pept Lett       Date:  2011-02       Impact factor: 1.890

3.  PINK1 stimulates interleukin-1β-mediated inflammatory signaling via the positive regulation of TRAF6 and TAK1.

Authors:  Hyun Jung Lee; Sung Hee Jang; Hyeyoung Kim; Joo Heon Yoon; Kwang Chul Chung
Journal:  Cell Mol Life Sci       Date:  2012-05-29       Impact factor: 9.261

4.  Impaired neurotransmitter release in Alzheimer's and Parkinson's diseases.

Authors:  Jie Shen
Journal:  Neurodegener Dis       Date:  2010-02-18       Impact factor: 2.977

5.  Cytosolic cleaved PINK1 represses Parkin translocation to mitochondria and mitophagy.

Authors:  Maja A Fedorowicz; Rosa L A de Vries-Schneider; Cornelia Rüb; Dorothea Becker; Yong Huang; Chun Zhou; Dana M Alessi Wolken; Wolfgang Voos; Yuhui Liu; Serge Przedborski
Journal:  EMBO Rep       Date:  2013-12-15       Impact factor: 8.807

6.  PINK1 is degraded through the N-end rule pathway.

Authors:  Koji Yamano; Richard J Youle
Journal:  Autophagy       Date:  2013-04-17       Impact factor: 16.016

Review 7.  DJ-1, PINK1, and their effects on mitochondrial pathways.

Authors:  Mark R Cookson
Journal:  Mov Disord       Date:  2010       Impact factor: 10.338

8.  PINK1 Content in Mitochondria is Regulated by ER-Associated Degradation.

Authors:  Cristina Guardia-Laguarta; Yuhui Liu; Knut H Lauritzen; Hediye Erdjument-Bromage; Brittany Martin; Theresa C Swayne; Xuejun Jiang; Serge Przedborski
Journal:  J Neurosci       Date:  2019-07-12       Impact factor: 6.167

9.  PINK1 rendered temperature sensitive by disease-associated and engineered mutations.

Authors:  Derek P Narendra; Chunxin Wang; Richard J Youle; John E Walker
Journal:  Hum Mol Genet       Date:  2013-03-03       Impact factor: 6.150

Review 10.  The PINK1/Parkin pathway: a mitochondrial quality control system?

Authors:  Alexander J Whitworth; Leo J Pallanck
Journal:  J Bioenerg Biomembr       Date:  2009-12       Impact factor: 2.945

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.